ALBO

Albireo Pharma, Inc. Common Stock
ALBO

Overview Fund Activity
Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

96 hedge funds and large institutions have $362M invested in Albireo Pharma, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 31 reducing their positions, and 13 closing their positions.

Holders
96
Holders Change
+2
Holders Change %
+2.13%
% of All Funds
1.48%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
15
Increased
34
Reduced
31
Closed
13
Calls
$1.99M
Puts
$886K
Net Calls
+$1.1M
Net Calls Change
+$1.17M

Top Buyers

1
PFM
1
Privium Fund Management
Netherlands
$8.96M
2
MCM
2
MAI Capital Management
Ohio
$3.25M
3
PIM
3
Platinum Investment Management
Australia
$7.35M
4
PM
4
Prosight Management
Texas
$12M
5
GKIM
5
GW&K Investment Management
Massachusetts
$7.6M

Top Sellers

1
BBA
1
Baker Bros. Advisors
New York
$2.43M
2
Marshall Wace
2
Marshall Wace
United Kingdom
$3.01M
3
State Street
3
State Street
Massachusetts
$23.1M
4
ECM
4
Endurant Capital Management
California
$1.53M
5
RHJA
5
Rice Hall James & Associates
California
$10.7M
Name Market Value Shares Shares
Change 		Shares
Change %
SG Americas Securities
101
SG Americas Securities
New York
– – -7,339 Closed
UBS AM
102
UBS AM
Illinois
– – -7,337 Closed
Invesco
103
Invesco
Georgia
– – -7,132 Closed
VOYA Investment Management
104
VOYA Investment Management
Georgia
– – -6,959 Closed
BFM
105
Boothbay Fund Management
New York
– – -6,845 Closed
VEA
106
Virtus ETF Advisers
New York
– – -6,197 Closed
CG
107
Cutler Group
California
– – -100 Closed
S
108
SignatureFD
Georgia
– – -33 Closed
EI
109
Ellevest Inc
New York
$0 6 – –
CFGS
110
Concourse Financial Group Securities
Alabama
– – – –
1 2 3 4
5